Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6–59 months

Published 2009 View Full Article

Authors

Keywords

Journal

VACCINE

Volume 27, Issue 47, Pages 6589-6594

Publisher

Elsevier BV

Online

2009-08-28

DOI

10.1016/j.vaccine.2009.08.032

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

VACCINE

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Add your recorded webinar

Become a Peeref-certified reviewer